Learn More
Sodium deoxycholate monohydrate, 98%, Thermo Scientific Chemicals
Descrizione
Sodium deoxycholate monohydrate is used as a solubilization agent for estrogen synthetase from human placental microsomes. It is also used to study the immobilization of lipoxygenase in an alginate-silicate gel matrix and to investigate the in vitro dissolution of gall stones.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Sodium Deoxycholate Monohydrate is used as a solubilization agent for estrogen synthetase from human placental microsomes. It is also used to study the immobilization of lipoxygenase in an alginate-silicate gel matrix and to investigate the in vitro dissolution of gall stones.
Solubility
Soluble in water.
Notes
Incompatible with oxidizing agents.
Specifica
Specifica
| Materiale o nome chimico | Sodium Deoxycholate Monohydrate |
| Punto di fusione | >300°C |
| Forma fisica | Powder |
| Quantità | 25 g |
| Intervallo percentuale saggio | 0.98 |
| Beilstein | 3643164 |
| Informazioni di solubilità | Soluble in water. |
| IUPAC Name | (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid;sodium;hydrate |
| Peso formulazione | 432.58 (414.58 Anhydrous) |
Sicurezza e movimentazione
- Sodium deoxycholate monohydrate
- Attenzione
- Tossicità acuta Categoria 4
- Tossicità specifica per organi bersaglio (esposizione singola) Categoria 3
- H302-Nocivo se ingerito.
- H335-Può irritare le vie respiratorie.
- P280-Indossare guanti/indumenti protettivi/Proteggere gli occhi/il viso.
- MIXTURE LIST-Contiene: Sodium deoxycholatemonohydrate
RUO – Research Use Only
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.